Poorest countries granted TRIPs extension

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Poorest countries granted TRIPs extension

Some of the world’s poorest countries will have access to affordable medicine for another eight years after WTO members agreed to extend the deadline for them to implement intellectual property provisions under the TRIPs Agreement.

Last week, the WTO issued a decision to extend the deadline for what it calls the “least developed countries” until July 1 2021, and said that a further extension may be possible when the time comes.

The previous deadline, which has already been extended once before, was July 1 2013.

The decision was made on the first day of a two-day meeting of the Trade-Related Aspects of Intellectual Property Rights (TRIPs) Council. Members unanimously agreed to the extension but had to resolve different views on the terms through negotiation.

At present, the WTO recognises 49 jurisdictions as “least developed countries”. Of these, 34 are members of the WTO.

The extension does not provide exempt the countries from their other obligations under the TRIPs Agreement, such as a separate transition period for them to protect patents covering pharmaceutical inventions.

“The agreement reached by members makes very clear that we can come together and get things done,” said WTO Director-General Pascal Lamy in a statement.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article